πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to SIGA Technologies, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

AT-527

Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics for viral infections, with a lead product candidate AT-527 for COVID-19 treatment.

Tags: COVID-19, antiviral, biopharmaceutical, clinical-stage, therapeutics

Symbol: AVIR

Recent Price: $3.33

Industry: Biotechnology

CEO: Dr. Jean-Pierre Sommadossi Ph.D.

Sector: Healthcare

Employees: 75

Address: 125 Summer Street, Boston, MA 02110

Phone: 857 284 8891

Leadership

  • Jean-Pierre Sommadossi, PhD, FOUNDER, CHAIRMAN & CEO
  • Nancy Agrawal, PhD, Executive VP, Preclinical Development
  • Jonae Barnes, Senior VP, Investor Relations & Corporate Communications
  • Bruce Belanger, PhD, Senior VP, Biostatistics
  • Andrea Corcoran, CFO & Executive VP, Legal
  • Adam DeZure, MD, VP, Clinical Development
  • James MB Evans, PhD, VP, CMC Manufacturing
  • Wayne Foster, EXECUTIVE VP, Chief Accounting Officer
  • Kerry Gagnon, VP, Head of Quality
  • Steven Good, EXECUTIVE VP, PRECLINICAL SCIENCE
  • Janet Hammond, MD, PhD, CHIEF DEVELOPMENT OFFICER
  • Arantxa Horga, MD, Chief Medical Officer
  • Qi Huang, Senior VP, Virology
  • Laura Ishak, Senior VP, Clinical Operations
  • Ariyapadi Krishnaraj, VP, Marketing
  • Adel Moussa, PhD, EXECUTIVE VP, CHEMISTRY
  • Shari Noble, VP, Deputy General Counsel
  • Keith Pietropaolo, Executive VP, Clinical Sciences and Project Management
  • Brian Rowe, VP, Business Development
  • Marc Van Hulle, VP, Finance
  • John Vavricka, CHIEF COMMERCIAL OFFICER
  • Alex Vo, PhD, VP, DMPK
  • Jayanthi Wolf, PhD, Executive VP, Regulatory Affairs
  • Xiao-Jian Zhou, PhD, EXECUTIVE VP, EARLY STAGE DEVELOPMENT

Last updated: 2024-12-31

ImmunityBio, Inc.

ImmunityBio, Inc. logo
Market Cap: High
Employees: Medium

Therapies and Vaccines

Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.

Tags: biotechnology, cancer, cell therapy, immunotherapy, infectious diseases, vaccines

Symbol: IBRX

Recent Price: $2.68

Industry: Biotechnology

CEO: Mr. Richard Gerald Adcock

Sector: Healthcare

Employees: 622

Address: 3530 John Hopkins Court, San Diego, CA 92121

Phone: 858 633 0300

Last updated: 2024-12-31

Novavax, Inc.

Novavax, Inc. logo
Market Cap: High
Employees: Medium

NVX-Co V2373

Novavax, Inc. is a biotechnology company focused on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Their vaccine candidates include NVX-Co V2373, Nano Flu, and Res Vax. The company operates collaboratively with Takeda Pharmaceutical Company Limited on COVID-19 vaccine development.

Tags: COVID-19, biotechnology, clinical trials, infectious diseases, vaccines

Symbol: NVAX

Recent Price: $7.93

Industry: Biotechnology

CEO: Mr. John Charles Jacobs M.B.A.

Sector: Healthcare

Employees: 1543

Address: 21 Firstfield Road, Gaithersburg, MD 20878

Phone: 240 268 2000

Last updated: 2024-12-31

Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Immuno Phage platform

Sensei Biotherapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of immunotherapies for cancer, leveraging platforms such as Immuno Phage and Tumor Microenvironment Activated Biologics.

Tags: bacteriophage, biopharmaceutical, cancer treatment, immunotherapy, monoclonal antibodies

Symbol: SNSE

Recent Price: $0.48

Industry: Biotechnology

CEO: Mr. John K. Celebi M.B.A.

Sector: Healthcare

Employees: 28

Address: 451 D Street, Rockville, MD 02210

Phone: 240 243 8000

Last updated: 2024-12-31

T2 Biosystems, Inc.

T2 Biosystems, Inc. logo
Market Cap: Lowest
Employees: Low

T2Dx Instrument

T2 Biosystems, Inc. develops in vitro diagnostic products for detecting pathogens, biomarkers, and abnormalities in various patient sample types.

Tags: SARS-CoV-2, T2Dx Instrument, bacterial pathogens, biomarkers, biothreat detection, candidemia, carbapenem resistance, in vitro diagnostics, pathogen detection, sepsis

Symbol: TTOO

Recent Price: $0.42

Industry: Medical - Diagnostics & Research

CEO: Mr. John J. Sperzel III, B.Sc.

Sector: Healthcare

Employees: 113

Address: 101 Hartwell Avenue, Lexington, MA 02421

Phone: 781 761 4646

Leadership

  • John Sperzel, Chairman and Chief Executive Officer
  • Michael Gibbs, Esq., SVP and General Counsel
  • Brett Giffin, Chief Commercial Officer
  • Kelley Morgan, Chief People Officer
  • Roger Smith, SVP, Science, Research and Development
  • John Sprague, Chief Financial Officer
  • Laura Adams, Special Advisor at the National Academy of Medicine (NAM)
  • John W. Cumming, CEO and Managing Director, Cumming & Associates LLC
  • David Elsbree, Former Senior Partner, Deloitte & Touche
  • Dr. Ninfa M. Saunders, FACHE, President and CEO, Navicent Health
  • Robin Toft, Founder and CEO, Toft Group

Last updated: 2024-12-31

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. logo
Market Cap: Lowest
Employees: Low

TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.

Tags: CNS, autoimmunity, biopharmaceutical, cancer, immunology, infectious disease, rare disease, therapeutics

Symbol: TNXP

Recent Price: $0.36

Industry: Biotechnology

CEO: Dr. Seth Lederman M.D.

Sector: Healthcare

Employees: 103

Address: 26 Main Street, Chatham, NJ 07928

Phone: 862 799 8599

Last updated: 2024-12-31

Aditxt, Inc.

Aditxt, Inc. logo
Market Cap: Lowest
Employees: Lowest

Aditxt Score

Aditxt, Inc. is a biotech company focused on developing technologies to improve immune system health through immune mapping and reprogramming. Their products include Aditxt Score for immune profiling and Apoptotic DNA Immunotherapy for inducing immune tolerance, with applications in organ transplantation, autoimmune diseases, and allergies.

Tags: biotech, health technology, immune mapping, immune reprogramming, immune system

Symbol: ADTX

Recent Price: $0.20

Industry: Biotechnology

CEO: Mr. Amro A. Albanna

Sector: Healthcare

Employees: 47

Address: 737 North Fifth Street, Richmond, VA 23219

Phone: 909 488 0844

Last updated: 2024-12-31

Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

Sig Nature, Sig Nify, Certain T

Applied DNA Sciences, Inc. develops DNA-based technology solutions for diagnostics, drug development, and supply chain security, offering products like Sig Nature molecular tags, Sig Nify portable DNA readers, and Certain T platforms.

Tags: DNA-based technology, anti-counterfeiting, molecular authentication, preclinical drug development, supply chain security

Symbol: APDN

Recent Price: $0.21

Industry: Medical - Diagnostics & Research

CEO: Dr. James A. Hayward Ph.D., Sc.D.

Sector: Healthcare

Employees: 52

Address: 50 Health Sciences Drive, Stony Brook, NY 11790

Phone: 631 840 8800

Last updated: 2024-12-31

Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

Endoxifen

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for oncology and infectious diseases with key programs in breast cancer and COVID-19 treatment.

Tags: COVID-19, Endoxifen, biopharmaceutical, breast cancer, infectious diseases, oncology

Symbol: ATOS

Recent Price: $0.97

Industry: Biotechnology

CEO: Dr. Steven C. Quay FCAP, M.D., Ph.D.

Sector: Healthcare

Employees: 12

Address: 107 Spring Street, Seattle, WA 98104

Phone: 206 588 0256

Last updated: 2024-12-31

89bio, Inc.

89bio, Inc. logo
Market Cap: Medium
Employees: Low

pegozafermin

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.

Tags: biopharmaceutical, cardio-metabolic, clinical-stage, hypertriglyceridemia, liver diseases, nonalcoholic steatohepatitis, pegozafermin

Symbol: ETNB

Recent Price: $7.87

Industry: Biotechnology

CEO: Mr. Rohan Palekar

Sector: Healthcare

Employees: 70

Address: 142 Sansome Street, San Francisco, CA 94104

Phone: 415 432 9270

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

GeoVax Labs, Inc.

GeoVax Labs, Inc. logo
Market Cap: Lowest
Employees: Lowest

Modified Vaccinia Ankara Virus-Like Particle Vaccine Platform

Geo Vax Labs, Inc. develops human vaccines and immunotherapies against infectious diseases and cancers using its proprietary modified vaccinia ankara virus-like particle vaccine platform. The company focuses on preventive vaccines for diseases like COVID-19, HIV, Zika, malaria, and hemorrhagic fever viruses, as well as therapeutic vaccines for HIV and chronic Hepatitis B.

Tags: biotechnology, cancer, immunotherapy, infectious diseases, vaccines

Symbol: GOVX

Recent Price: $2.44

Industry: Biotechnology

CEO: Mr. David Alan Dodd

Sector: Healthcare

Employees: 17

Address: 1900 Lake Park Drive, Smyrna, GA 30080

Phone: 678 384 7220

Last updated: 2024-12-31

Immunome, Inc.

Immunome, Inc. logo
Market Cap: Medium
Employees: Low

IMM-ONC-01, IMM-BCP-01

Immunome, Inc. is a biopharmaceutical company focused on developing antibody therapeutics for oncology and infectious diseases, offering innovative solutions such as IMM-ONC-01 for cancer and IMM-BCP-01 for COVID-19 treatment.

Tags: antibody therapeutics, biopharmaceutical, infectious disease, oncology

Symbol: IMNM

Recent Price: $10.28

Industry: Biotechnology

CEO: Dr. Clay B. Siegall Ph.D.

Sector: Healthcare

Employees: 78

Address: 665 Stockton Drive, Exton, PA 19341

Phone: 610 321 3700

Last updated: 2024-12-31

Vaxcyte, Inc.

Vaxcyte, Inc. logo
Market Cap: Highest
Employees: Low

VAX-24

Vaxcyte, Inc. is a clinical-stage biotechnology company developing novel protein vaccines for preventing or treating bacterial infectious diseases. Key products include the VAX-24 pneumococcal conjugate vaccine and other candidates targeting antibiotic resistance and periodontitis.

Tags: bacterial infectious diseases, biotechnology, clinical-stage, pharmaceuticals, protein vaccines, vaccines

Symbol: PCVX

Recent Price: $81.99

Industry: Biotechnology

CEO: Mr. Grant E. Pickering M.B.A.

Sector: Healthcare

Employees: 254

Address: 825 Industrial Road, San Carlos, CA 94070

Phone: 650 837 0111

Last updated: 2024-12-31

TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

TTX-MC138

Trans Code Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs and diagnostics for treating metastatic disease. Their lead product, TTX-MC138, is aimed at metastatic cancer treatment, along with a range of other therapeutic platforms targeting cancer through innovative RNA- and CRISPR-based technologies.

Tags: CRISPR technology, RNA-based therapy, biopharmaceutical, cancer treatment, metastatic disease

Symbol: RNAZ

Recent Price: $3.76

Industry: Biotechnology

CEO: Mr. Thomas A. Fitzgerald M.B.A.

Sector: Healthcare

Employees: 10

Address: 6 Liberty Square, Boston, MA 02109

Phone: 857-837-3099

Last updated: 2024-12-31

SIGA Technologies, Inc.

SIGA Technologies, Inc. logo
Market Cap: Medium
Employees: Lowest

TPOXX

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product, TPOXX, is an antiviral drug for treating human smallpox disease.

Tags: TPOXX, antiviral drug, biothreats, health security, infectious diseases, pharmaceutical, smallpox

Symbol: SIGA

Recent Price: $5.92

Industry: Drug Manufacturers - Specialty & Generic

CEO: Dr. Diem Nguyen M.B.A., Ph.D.

Sector: Healthcare

Employees: 45

Address: 31 East 62nd Street, New York, NY 10065

Phone: 212 672 9100

Last updated: 2024-12-31

Vir Biotechnology, Inc.

Vir Biotechnology, Inc. logo
Market Cap: Medium
Employees: Medium

Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111

Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.

Tags: COVID-19, HIV, biotechnology, hepatitis B, immunology, infectious diseases, influenza, therapeutics

Symbol: VIR

Recent Price: $7.33

Industry: Biotechnology

CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.

Sector: Healthcare

Employees: 587

Address: 499 Illinois Street, San Francisco, CA 94158

Phone: 415 906 4324

Leadership

  • Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
  • Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
  • Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
  • Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
  • Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
  • Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
  • Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
  • Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
  • Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
  • Arran Attridge, Senior Vice President Corporate Communications
  • Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
  • Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow

Last updated: 2024-12-31

vTv Therapeutics Inc.

vTv Therapeutics Inc. logo
Market Cap: Lowest
Employees: Lowest

TTP399

v Tv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing orally administered treatments for diabetes and other diseases. Key products include TTP399 for type 1 diabetes and HPP737 for inflammatory diseases.

Tags: HPP737, TTP399, biopharmaceutical, chronic diseases, clinical-stage, diabetes treatment

Symbol: VTVT

Recent Price: $13.97

Industry: Biotechnology

CEO: Mr. Paul J. Sekhri M.Sc.

Sector: Healthcare

Employees: 16

Address: 3980 Premier Drive, High Point, NC 27265

Phone: 336 841 0300

Last updated: 2024-12-31

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation logo
Market Cap: Medium
Employees: Medium

immunoSEQ

Adaptive Biotechnologies Corporation is a commercial-stage company that develops an immune medicine platform for diagnosing and treating various diseases, including COVID-19 and lymphoid cancers.

Tags: COVID-19, cancer, diagnostics, immune medicine, immunosequencing, translational research

Symbol: ADPT

Recent Price: $6.11

Industry: Biotechnology

CEO: Mr. Chad M. Robins M.B.A.

Sector: Healthcare

Employees: 709

Address: 1165 Eastlake Avenue East, Seattle, WA 98109

Phone: 206 659 0067

Last updated: 2024-12-31

Tango Therapeutics, Inc.

Tango Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

TNG908

Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.

Tags: BRCA1/2-mutant cancers, Gilead Sciences, STK11-mutant cancers, TNG908, biotechnology, cancer treatment, drug development, methylthioadenosine phosphorylase, protein arginine methyltransferase 5, strategic collaboration, synthetic lethal

Symbol: TNGX

Recent Price: $3.10

Industry: Biotechnology

CEO: Dr. Barbara L. Weber M.D.

Sector: Healthcare

Employees: 140

Address: 100 Binney Street, Cambridge, MA 02142

Phone: 857 320 4900

Last updated: 2024-12-31